PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Two Industry Leaders - Proliant Health and Biologicals and Lampire Biological Laboratories - Form Strategic Partnership to Provide Bovine Serum Albumin

This partnership will meet market needs with quality, value and flexibility.

Two Industry Leaders - Proliant Health and Biologicals and Lampire Biological Laboratories - Form Strategic Partnership to Provide Bovine Serum Albumin
2010-08-09
SAN FRANCISCO, CA, August 09, 2010 (Press-News.org) Lampire Biological Laboratories (LBL) announced today that it signed an agreement with Proliant Health and Biologicals (Proliant), manufacturer of the worlds most trusted, high quality Bovine Serum Albumin (BSA), to do contract filling & provide BSA to customers requiring less than Proliant's standard 10 kilogram packaging. Lampire will also offer made-to-order aqueous blends in buffers and package sizes to customer specifications.

Stephen Welch, President & CEO of Proliant, said, "Proliant has become the pre-eminent bulk manufacturer of BSA, currently supplying over half of global demand. As part of this rapid growth, Proliant is committed to supplying customers who require smaller quantities of BSA the same value large scale customers enjoy, plus a greater degree of flexibility and customer service." Stephen went on to say, "The search is now over; Lampire with its contract manufacturing abilities, plus an extensive knowledge of the diagnostic and pharmaceutical industries, fulfills every attribute Proliant requires."

According to Gregory F. Krug, President & CEO of LBL, "The applications for BSA are truly endless and we are proud to enter into this strategic partnership with Proliant." Greg went on to say, "...we are looking at drug development labs, academic research institutes, biotech companies and antibody suppliers all of which need high quality BSA. The Lampire Business Model will allow us to provide them with high quality BSA in a variety of forms and formulations in a most cost-effective manner."

About Lampire Biological Laboratories
Lampire Biological Laboratories specializes in polyclonal and monoclonal antibody development, cell culture devices and services, and a wide variety of blood-derived products. Founded in 1977, the Pennsylvania based company offers an extensive line of secondary antibodies, purified IgGs, human and animal blood products, plus a comprehensive line of animal tissues and organs. The latest product and service releases include novel teratogenicity screening assays, New Zealand sourced animal blood products, the gas-permeable LAMPIRE OMNI C3 Cell Culture Bag, exclusive antibodies to chemotherapeutic agents, and Proliant BSA. Additional services include peptide synthesis, antigen design, antibody purification, custom conjugation, immunoassay development, and contract manufacturing. Lampire is a privately held company.

About Proliant Health and Biologicals
Proliant, a privately held company, is the world's largest producer of bovine plasma derivatives, such as BSA. Derived from the plasma of healthy, US-origin animals with complete traceability, Proliant's bovine serum albumin exceeds 99% purity and is suitable for diagnostic, pharmaceutical, veterinary, and research applications.

Proliant Health and Biologicals specializes in the development of ingredients from natural sources for the human health and nutrition industry, including the dietary supplement, clinical nutrition, consumer health and functional food markets. Proliant has developed exciting new technologies to isolate bio-active proteins and peptides that play vital roles in human health. The most well-known of these are immunoglobulins.

Proliant ingredients are unsurpassed in innovation and quality, which allows them to be used in the most sensitive nutritional applications. ImmunoLin is an immunoglobulin protein isolate which can be used for tablets, capsules, drink mixes, lozenges and bars.

Contacts:

Lampire Biological Laboratories
Gregory F. Krug
President
Office: 215-795-2838
Website: http://www.proliantinc.com

or

Proliant Health & Biologicals
Jim Torvik
Director of Sales and Marketing
Office: 515-289-5142
Mobile: 515-494-0700

[Attachments] See images for this press release:
Two Industry Leaders - Proliant Health and Biologicals and Lampire Biological Laboratories - Form Strategic Partnership to Provide Bovine Serum Albumin

ELSE PRESS RELEASES FROM THIS DATE:

Whataburger Asks Customers: "Tell Us Why You're Our Biggest Fan!"

Whataburger Asks Customers: Tell Us Why Youre Our Biggest Fan!
2010-08-09
Southern burger icon Whataburger celebrates its 60th anniversary with its "Tell Us Why You're Our Biggest Fan" online contest. At stake is a Whataburger fan's dream come true: 60 years of free Whataburger, a trip to the Whataburger convention in Dallas, TX and other cool prizes! Beginning August 4 and all throughout the company's anniversary month of August, fans can submit either videos or essays with photos at www.whataburger.com, demonstrating why they are Whataburger's biggest fans. The first 60 fans to enter will win a coupon for a free Whataburger. The contest ...

LAST 30 PRESS RELEASES:

Mind the seismic gap: Understanding earthquake types in Guerrero, Mexico

One hour’s screen use after going to bed increases your risk of insomnia by 59%, scientists find

Canada needs to support health research at home and abroad

Cannabis use disorder among insured pregnant women in the US between 2015-2020

Education system needs overhaul to support school anxiety, psychologists say

Play “humanizes” pediatric care and should be key feature of a child-friendly NHS – report

Stricter oversight needed as financial misconduct drives risk-taking in banking

Cardiac arrest during long-distance running races

Preventable cardiac deaths during marathons are down, Emory study finds

New study finds peripheral artery disease often underdiagnosed and undertreated; opportunity to improve treatments, lower death rates

Use of antidepressant medication linked to substantial increase in risk of sudden cardiac death 

Atrial fibrillation diagnosed in midlife is linked to a 21% increased risk of dementia at any age and a 36% higher risk of early-onset dementia 

Mode of death in patients with heart failure with mildly reduced or preserved ejection fraction

Intravenous ferric carboxymaltose in heart failure with iron deficiency

Artificial intelligence in the prevention of sudden death

Oral semaglutide vastly reduces heart attacks, strokes in people with type 2 diabetes

Prothrombin complex concentrate vs frozen plasma for coagulopathic bleeding in cardiac surgery

Who needs a statin? New study compares prescribing recommendations based on traditional risk factors vs. coronary artery calcium scoring

Finerenone and atrial fibrillation in heart failure

Low coronary artery calcium score is associated with an excellent prognosis regardless of a person’s age, new study finds

Groundbreaking consensus statement on conduction system pacing released: a major milestone in the evolution of pacing therapy

Nuclear monitoring system suggests landslide cut off internet in west Africa

PNNL scientist elected AAAS fellow

American College of Cardiology recognizes five JACC Rocket Fuel Consultants

American College of Cardiology, Association of Black Cardiologists recognize three Merck Research Fellowship awardees

JACC to recognize 2025 Simon Dack Award recipients, Elite Reviewers

American College of Cardiology honors two recipients with the William A. Zoghbi Global Research Initiative Award

JACC recognizes five recipients of the William W. Parmley Young Author Achievement Award

Mass General Brigham researchers identify mutations that can lead to resistance to some chemotherapies

JACC journals honor 10 young researchers

[Press-News.org] Two Industry Leaders - Proliant Health and Biologicals and Lampire Biological Laboratories - Form Strategic Partnership to Provide Bovine Serum Albumin
This partnership will meet market needs with quality, value and flexibility.